转移性肛门癌的治疗

IF 2.4 4区医学 Q3 ONCOLOGY

Surgical Oncology Clinics of North America Pub Date : 2024-09-10 DOI:10.1016/j.soc.2024.08.001

Joseph Do Woong Choi BSc (Adv), MBBS, MPhil, FRACS , Devansh Shah MBBS (Hons), MS , Toufic El-Khoury MBBS, MS, FACS, FRACS , Nimalan Pathma-Nathan MBBS, FRACS , James Wei Tatt Toh MBBS, FRACS, FACS, PhD

引用次数: 0

摘要

肛管转移性鳞状细胞癌是一种罕见的病变，怀疑患者存在风险因素，如已知的原发性肛门癌、人类乳头状瘤病毒/人类免疫缺陷病毒、免疫抑制、吸烟和肛门性交。患者可能在肛门癌发病初期出现转移，也可能在原发肿瘤化疗后出现转移。治疗重点是采用化疗进行全身治疗，并考虑将免疫疗法作为二线疗法。预测性生物标志物可能会在未来实现个性化治疗。目前正在积极开展不同化疗和免疫疗法组合的临床试验，以改善目前的治疗方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Management of Metastatic Anal Cancer

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Surgical Oncology Clinics of North America 医学-外科

CiteScore

3.90

自引率

0.00%

发文量

审稿时长

12 months

期刊介绍： Published four times each year—January, April, July, and October—Surgical Oncology Clinics of North America updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in surgical oncology, including pancreatic cancer, radiation oncology, breast cancer, colorectal cancer, head and neck cancer, palliative care, gene therapy, sarcomas, cancer screening, treatment of colorectal cancer, biliary tract and primary liver tumors, breast cancer, imaging, and more.